At Dana-Farber, Mr. McCormick will oversee the planning and development of a proposed 300-bed cancer center in partnership with Beth Israel Deaconess Medical Center and Harvard Medical Faculty Physicians, according to a July 24 news release.
Last year, Dana-Farber and BIDMC shared plans to collaborate on a freestanding inpatient cancer hospital in Boston, marking a significant change in the city’s cancer landscape. Since 1997, Dana-Farber has been clinically affiliated with Brigham and Women’s Hospital, also based in Boston. Their partnership runs through 2028.
In a news release, Dana-Farber referenced Mr. McCormick’s “successful record of building high-functioning teams that align on shared vision and common goals.” At OHSU, he co-led the design and implementation of an ambulatory cancer clinic. More recently, he oversaw a 500,000-square-foot inpatient addition that includes 129 beds for advanced therapies and complex surgery.
